← Back to Search

Continuous Glucose Monitor

Continuous Glucose Monitor (CGM) for Diabetes

N/A
Waitlist Available
Led By Adrian Dumitrascu, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of enrollment and until discharge from the hospital up to 30 days.
Awards & highlights

Study Summary

This study is evaluating whether continuous glucose monitors are accurate for blood glucose monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of enrollment and until discharge from the hospital up to 30 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of enrollment and until discharge from the hospital up to 30 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CGM accuracy
Secondary outcome measures
CGM recorded hyperglycemia episodes
CGM recorded hypoglycemia episodes

Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM PatientsExperimental Treatment1 Intervention
Subjects with diabetes mellitus or medication induced diabetes that have been admitted to the hospital after a surgery for organ transplantation or scheduled for organ transplant surgery will be fitted with a CGM monitor to monitor glucose levels during hospitalization
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous Glucose Monitor (CGM)
2017
Completed Phase 3
~650

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,212 Previous Clinical Trials
3,766,988 Total Patients Enrolled
22 Trials studying Diabetes
6,803 Patients Enrolled for Diabetes
Adrian Dumitrascu, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
270 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~33 spots leftby Nov 2025